Forum: Clinical Trials
01-06-2014, 05:27 PM
|
|
Replies: 9
Views: 22,216
Re: Tivatinib (ARQ-197)
Elizabeth
If you think of it like the alphabet it becomes less formidble. To say P13K to AKT to MTor is just like saying A B C.
Your idea of a P13K inhibitor makes a lot of sense. There is...
|
|
Forum: Clinical Trials
01-05-2014, 07:01 PM
|
|
Replies: 9
Views: 22,216
Re: Tivatinib (ARQ-197)
Elizabeth
Since you are interested in this Ill show you how complicated it gets. Affinitor is an anticancer drug that inhibits M-Tor. There are two froms of M-Tor and Affinitor mostly inhibits...
|
|
Forum: Clinical Trials
01-05-2014, 04:11 PM
|
|
Replies: 9
Views: 22,216
Re: Tivatinib (ARQ-197)
I read the article on C-MET and learned a lot. I dont know if it would make sense putting it on the board. Its sort of an A-B-C-D-E-F thing, A being C-met which is connected to another protein (B)...
|
|
Forum: Clinical Trials
01-03-2014, 10:59 PM
|
|
Replies: 9
Views: 22,216
Re: Tivatinib (ARQ-197)
Ill do some research on it. What i put down was very preliminary. I sent an article on the Hepatocyte Growth factor to my wife's computer at work and Ill read it tonight. Tivatinib or ARK-197...
|
|
Forum: Clinical Trials
01-03-2014, 12:23 AM
|
|
Replies: 9
Views: 22,216
Re: Tivatinib (ARQ-197)
I found another article I xeroxed from the Pharmacy I last worked at about ARQ-197 (Tivatinib).
For one thing there were some prolonged stablization of disease when ARQ-197 was given in...
|
|
Forum: Clinical Trials
01-02-2014, 11:46 PM
|
|
Replies: 9
Views: 22,216
Tivatinib (ARQ-197)
I dont know if this investigational drug has been mentioned before. It is an inhibitor of C-MET which is the Hepatocyte Growth Factor Tyrosine Kinase. Apparently C-Met is overactive in various...
|
